Assessment of functional capacity of teens who are Mucopolysaccharidosis type II carriers
Introduction: Mucopolysaccharidosis II (MPS II) is an X-linked genetic disease which almost exclusively affects males. The disease presents a multisystem form, caused by the progressive accumulation of glycosaminoglycans (GAGs) in tissues and organs. It causes developmental delays resulting in limi...
Main Authors: | Ingrid Alves Barros Silva Amaral, Reinaldo Luna de Omena Filho, João Ancelmo dos Reis Neto, Monique Carla da Silva Reis |
---|---|
Format: | Article |
Language: | Portuguese |
Published: |
Universidade Federal de São Carlos
2017-06-01
|
Series: | Cadernos Brasileiros de Terapia Ocupacional |
Subjects: | |
Online Access: | http://www.cadernosdeterapiaocupacional.ufscar.br/index.php/cadernos/article/view/1261/865 |
Similar Items
-
Newborn Screening for Mucopolysaccharidosis Type II in Illinois: An Update
by: Barbara K. Burton, et al.
Published: (2020-09-01) -
The importance of the otorhinolaryngologic evaluation in mucopolysaccharidosis patients
by: Bicalho, Cibele Gomes, et al.
Published: (2011-07-01) -
SURGICAL TREATMENT OF CERVICAL STENOSIS IN PATIENTS WITH MUCOPOLYSACCHARIDOSIS: SYSTEMATIC REVIEW
by: S. V. Kolesov, et al.
Published: (2018-07-01) -
Impact of intracerebroventricular enzyme replacement therapy in patients with neuronopathic mucopolysaccharidosis type II
by: Joo-Hyun Seo, et al.
Published: (2021-06-01) -
Clinical, Biochemical and Molecular Characteristics of Fifteen Patients with Mucopolysaccharidosis Type II in Western Turkey
by: Havva Yazıcı, et al.
Published: (2018-03-01)